Putnam Global Health Care R6 holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Putnam Global Health Care Fund Class R6 Shares PGHAX
- NAV / 1-Day Return 73.89 / +1.37 %
- Total Assets 1.5B
-
Adj. Expense Ratio
0.700%
- Expense Ratio 0.700%
- Distribution Fee Level Low
- Share Class Type Retirement, Large
- Category Health
- Investment Style Large Value
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.45%
- Turnover 67%
USD | NAV as of Jul 22, 2026 | 1-Day Return as of Jul 22, 2026, 12:11 AM GMT+0
Morningstar’s Analysis PGHAX
Will PGHAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 61.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 13.63 | 209M | Healthcare |
Johnson & Johnson | 9.11 | 140M | Healthcare |
UnitedHealth Group Inc | 7.24 | 111M | Healthcare |
AbbVie Inc | 6.68 | 102M | Healthcare |
Merck & Co Inc | 5.51 | 84M | Healthcare |
Novartis AG Registered Shares | 5.10 | 78M | Healthcare |
AstraZeneca PLC | 4.49 | 69M | Healthcare |
Intuitive Surgical Inc | 3.61 | 55M | Healthcare |
Thermo Fisher Scientific Inc | 3.33 | 51M | Healthcare |
CVS Health Corp | 2.97 | 46M | Healthcare |